ESKA PHARMA
ActiveESKA PHARMA has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €585k and a net result of €57k. Equity is growing by ~17.3% per year across the filed fiscal years. Its solvency ranks better than 32% of 37972 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2024
70
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability73▲+6
Solvency61▲+4
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity short (current ratio 0.04 against 0.19 in 2023; short-term debt: 10.5% and cash: 0% of total assets), and 63.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-10-2025, 89 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
89 d late
2023
90 d late
2022
92 d late
2021
169 d late
2020
90 d late
2019
116 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€57k▲ 214%
2023 · €18k
2018: €32k
2019: €-47k
2020: €4k
2021: €56k
2022: €213k
2023: €18k
2018 → 2024
Working capital
€-163k▼ 1.6%
2023 · €-160k
2018: €-170k
2019: €-134k
2020: €-162k
2021: €-156k
2022: €-123k
2023: €-160k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€267k-€323k▲ 20.8%€510k▲ 57.9%€528k▲ 3.6%€585k▲ 10.8%
Operating result€41k-€56k▲ 36.7%€266k▲ 375%€73k▼ 72.5%€96k▲ 31.8%
Net result€4k-€56k▲ 1,300%€213k▲ 283%€18k▼ 91.5%€57k▲ 214%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 32% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.61M
Fixed assets
€1.61M▼ 0.9%
Current assets
€7k▼ 80.2%
Equity and liabilities €1.61M
Equity
€585k▲ 10.8%
Debt
€1.03M▼ 9.0%
The debt ratio falls from 68.2% to 63.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€111k▲
2023 · €88k
Cash flow
€72k▲
2023 · €33k
Solvency
36.2%▲
2023 · 31.8%
Current ratio
0.04▼
2023 · 0.19
Quick ratio
0.04▼
2023 · 0.19
Debt / equity
1.76▼
2023 · 2.14
ROE
9.7%▲
2023 · 3.4%
ROA
3.5%▲
2023 · 1.1%
Interest coverage
7.25▲
2023 · 5.67
Debt
€1.03M▼
2023 · €1.13M
Debt ≤ 1 year
€170k▼
2023 · €197k
Debt > 1 year
€859k▼
2023 · €934k
Income taxes
€24k▼
2023 · €39k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€1.66M€1.61M▼
Fixed assets21/28€1.62M€1.61M▼
Tangible fixed assets22/27€674k€659k▼
Land and buildings22€674k€659k▼
Financial fixed assets28€948k€948k=
Current assets29/58€37k€7k▼
Amounts receivable within one year40/41€20k€7k▼
Other amounts receivable41€20k€7k▼
Current investments50/53€6k-
Cash at bank and in hand54/58€11k€716▼
Equity and liabilities
Total equity and liabilities10/49€1.66M€1.61M▼
Equity10/15€528k€585k▲
Contributions10/11€12k€12k=
Reserves13€315k€415k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€314k€414k▲
Profit (loss) carried forward14€200k€157k▼
Amounts payable17/49€1.13M€1.03M▼
Amounts payable after more than one year17€934k€859k▼
Financial debts170/4€934k€859k▼
Amounts payable within one year42/48€197k€170k▼
Current portion of amounts payable after more than one year42€85k€80k▼
Trade debts44€1k€2k▲
Suppliers440/4€1k€2k▲
Taxes, remuneration and social security45€47k€11k▼
Taxes450/3€47k€11k▼
Other amounts payable47/48€64k€77k▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€15k=
Other operating charges640/8€5k€4k▼
Gross operating margin9900€93k€115k▲
Operating profit (loss)9901€73k€96k▲
Financial charges65/66B€16k€15k▼
Recurring financial charges65€16k€15k▼
Profit (loss) for the period before taxes9903€57k€81k▲
Income taxes67/77€39k€24k▼
Profit (loss) for the period9904€18k€57k▲
Profit (loss) for the period to be appropriated9905€18k€57k▲
Appropriation of the result
Profit (loss) to be appropriated9906€218k€257k▲
Profit (loss) brought forward from the previous period14P€200k€200k=
Transfer to equity691/2€18k€100k▲
To the legal reserve6920-€100k
To other reserves6921€18k-
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
28-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 89 days late
2024
29-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 90 days late
2023
31-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 92 days late
16-01
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 169 days late
2022
31-12
Financial
Highest result since 2018net €213k ▲283%
Operating result €266k, net result €213k, both a record.
31-12
Financial
Equity above €500kEq €510k ▲57.9%
3 profitable years in a row build equity to €510k.
2021
29-10
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 90 days late
2020
31-12
Financial
Back to profitnet €4k
Net result €4k after one loss-making year.
24-11
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 116 days late
2019
31-12
Financial
Weakest financial yearnet €-47k ▼245%
Net result drops to €-47k, the lowest in the series; recovery starts the following year.
25-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
03-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
20-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
2016
17-06
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Antoine Dansaertstraat 11000 BrusselGround area
115 m²
Building footprint
102 m²
Volume, LiDAR
2,052 m³
Parcel 21811M0784/00E000, Brussels · tallest building 22.7 m, ±7 floors. Linked by address, not a title deed.
1 establishment unit
ESKA PHARMA
since 20112.203.143.578
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21811M0784/00E000 | Brussels | 115 m² | 1 · 102 m² | 22.6 m · 7 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PARSIMONIA
BE 0414.491.787
Meise · Eq €585k
VAN HAVERMAET INTERNATIONAL
BE 0449.399.317
Hasselt · Eq €585k
FDTech
BE 0508.848.934
Destelbergen · Eq €585k
HURA
BE 0883.281.802
Beerse · Eq €585k
LAPIS LAZULI
BE 0897.806.363
Willebroek · Eq €585k
Of 82,524 companies in sector 70200 we hold annual accounts for 52,566. 33,346 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded06-10-2011
Fiscal year end31-12
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.